COMPANY
Saptalis Pharmaceuticals
Timeline
- Trial start Phase 2: Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection source ↗
- Trial start Phase 3: A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07146217 | Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection | Phase 2 | Not yet recruiting | 2025-08 | 2026-07 (estimated) |
| NCT03973775 | A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies | Phase 3 | Completed | Apr 10, 2018 | Nov 13, 2018 (actual) |